Is this stock overpriced or what?
I can buy a half dozen biotechs with approved drugs with a total capitalization less than $250M.
Who conned you into buying this overpriced dog?
Tang is looking for the door............what a #$%$!
Why do you care? Are you selling something
Sentiment: Strong Buy
Sareptas market cap: 1.18 billion and climbing. No approved drug, potential of 600 billion in sales per year.
Aloxis sales in 2011 by comparison: 532 million, estimated to be close to 600 million for year ended march 31 2012.
Thanks for pointing out another overpriced dung stock.